Literature DB >> 134947

[Cervical myelography with water-soluble contrast medium (Metrizamide). Technique and preliminary results (author's transl)].

H Vogelsang, O Busse, R Schmidt.   

Abstract

Use of a water-soluble contrast medium for cervical spinal diagnosis has become possible with the introduction of Metrizamide (Amipaqque). Injection of contrast at the C.1/2 level by a lateral approach results in excellent visualisation of the cervical theca with previously unobtainable detail. This technique, which is so far not well known, allows a rapid examination and when used with the new, well tolerated contrast media provides optimal diagnostic results.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 134947     DOI: 10.1055/s-0029-1230450

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

1.  Remarks about the paper by H.J. Gelmers: adverse side effects of metrizamide in myelography.

Authors:  R C Schmidt
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

2.  [Cervical myelography after lumbar application of metrizamide (author's transl)].

Authors:  H Krtsch; G Ritter
Journal:  Neuroradiology       Date:  1978       Impact factor: 2.804

3.  [Myelography with metrizamide. (Amipaque)].

Authors:  H Vogelsang; R Schmidt; O Busse; U Dangel
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

4.  Adverse side effects of metrizamide in myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

5.  [Myelography with metrizamide in children (author's transl)].

Authors:  R C Schmidt; H Vogelsang; F Grunwald
Journal:  Neuroradiology       Date:  1978       Impact factor: 2.804

6.  Exacerbation of systemic lupus erythematosus, aseptic meningitis and acute mental symptoms, following metrizamide lumbar myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.